May 2009 Research News
New Type of Targeted Therapy May Help Treat Triple-Negative Disease
May 31, 2009
Experimental targeted therapy medicines -- called PARP inhibitors -- may make chemotherapy work better against aggressive forms of breast cancer and also may be able to treat breast cancer alone, without chemotherapy. Read more...
Do Antidepressants Interfere with Tamoxifen? Results Unclear
May 30, 2009
While the results aren't definitive, one of two new studies suggests that women who take tamoxifen at the same time as the antidepressant medicines Prozac or Paxil may not get the full benefits of tamoxifen. Read more...
American Society Clinical Oncology Now Recommends Evista or Tamoxifen to Reduce Risk in High-Risk Women
May 26, 2009
New guidelines from the American Society of Clinical Oncology (ASCO) now recommend both tamoxifen and Evista (chemical name: raloxifene) to reduce breast cancer risk in post-menopausal women at high risk. Read more...
Breast Cancer Risk Factors Vary by Tumor Subtype
May 22, 2009
A new study found that certain risk factors for breast cancer affect the risk of specific types of breast cancer in different ways. Read more...
Adding Taxotere to Standard Chemo Doesn’t Seem to Help Treat Early-Stage Breast CancerMay 15, 2009
Taxotere doesn't seem to offer any benefits in treating early-stage breast cancer and also causes more serious side effects. Read more...
Older Women Do Better on Conventional Chemo Compared to Xeloda
May 13, 2009
Research shows that women older than 65 do better on standard intravenous chemotherapy after surgery to remove early-stage breast cancer than Xeloda (chemical name: capecitabine), an oral chemotherapy. Read more...
Molecular Test During Surgery May Help Find Cancer in Lymph Nodes
May 8, 2009
A test that quickly detects cancer cells in a lymph node during surgery to remove breast cancer is accurate enough to help doctors decide if lymph nodes need to be removed during the surgery. Read more...